EP 0828839 A1 19980318 - ANIMAL GENE THERAPY
Title (en)
ANIMAL GENE THERAPY
Title (de)
TIERISCHE GENTHERAPIE
Title (fr)
THERAPIE GENIQUE ANIMALE
Publication
Application
Priority
- CA 9600297 W 19960510
- GB 9509461 A 19950510
Abstract (en)
[origin: WO9635793A1] The present invention relates to DNA sequences, expression cassettes and DNA constructs for use in therapy, specifically in gene therapy for the treatment of infectious diseases such as mastitis. Also included are pharmaceutical and veterinary compositions containing the constructs, and cells which have been transformed with the DNA and which are suitable for implantation into a host mammal. The gene therapy of infectious diseases can be effected in situ in targeted tissue or systemically.
IPC 1-7
IPC 8 full level
A01K 67/027 (2006.01); A61K 31/70 (2006.01); A61K 35/76 (2006.01); A61K 48/00 (2006.01); A61P 31/00 (2006.01); C12N 5/00 (2006.01); C12N 5/10 (2006.01); C12N 9/52 (2006.01); C12N 15/09 (2006.01); C12N 15/55 (2006.01); C12N 15/85 (2006.01); C12R 1/91 (2006.01)
CPC (source: EP)
A61K 48/00 (2013.01); A61P 31/00 (2017.12); C12N 9/52 (2013.01); C12N 15/8509 (2013.01); A01K 2217/05 (2013.01); A01K 2227/10 (2013.01); A01K 2227/102 (2013.01); A01K 2227/103 (2013.01); A01K 2267/01 (2013.01); A01K 2267/02 (2013.01)
Citation (search report)
See references of WO 9635793A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9635793 A1 19961114; AU 5641696 A 19961129; AU 724905 B2 20001005; CA 2220472 A1 19961114; EP 0828839 A1 19980318; GB 9509461 D0 19950705; JP H11505113 A 19990518; MX 9708615 A 19980628; NZ 307139 A 19990830
DOCDB simple family (application)
CA 9600297 W 19960510; AU 5641696 A 19960510; CA 2220472 A 19960510; EP 96913403 A 19960510; GB 9509461 A 19950510; JP 53362796 A 19960510; MX 9708615 A 19971107; NZ 30713996 A 19960510